Lymph Node Yield as a Predictor of Survival in Pathologically Node Negative Oral Cavity Carcinoma

Abstract

Objective

Even after a pathologically node-negative (pN0) neck dissection for oral cavity squamous cell carcinoma (SCC), patients may develop regional recurrence. In this study, we (1) hypothesize that an increased number of lymph nodes removed (lymph node yield) in patients with pN0 oral SCC predicts improved survival and (2) explore predictors of survival in these patients using a multivariable model.

Study Design

Case series with chart review.

Setting

Administrative database analysis.

Subjects and Methods

The SEER database was queried for patients diagnosed with all-stage oral cavity SCC between 1988 and 2009 who were determined to be pN0 after elective lymph node dissection. Demographic and treatment variables were extracted. The association of lymph node yield with 5-year all-cause survival was studied with multivariable survival analyses.

Results

A total of 4341 patients with pN0 oral SCC were included in this study. The 2 highest lymph node yield quartiles (representing >22 nodes removed) were found to be significant predictors of overall survival (22-35 nodes: hazard ratio [HR] = 0.854, P = .031; 36-98 nodes: HR = 0.827, P = .010). Each additional lymph node removed during neck dissection was associated with increased survival (HR = 0.995, P = .022).

Conclusion

These data suggest that patients with oral SCC undergoing elective neck dissection may experience an overall survival benefit associated with greater lymph node yield. Mechanisms behind the demonstrated survival advantage are unknown. Larger nodal dissections may remove a greater burden of microscopic metastatic disease, diminishing the likelihood of recurrence. Lymph node yield may serve as an objective measure of the adequacy of lymphadenectomy.

Keywords

squamous cell carcinoma head and neck oral cavity lymph node lymph node yield neck dissection surgical outcomes SEER

Get full access to this article

View all access options for this article.

References

Byers

Wolf

Ballantyne

. Rationale for elective modified neck dissection. Head Neck Surg. 1988;10:160-167.

Shaw

Rumball

. Complications and local recurrence following lymphadenectomy. Br J Surg. 1990;77:760-764.

Weiss

Harrison

Isaacs

. Use of decision analysis in planning a management strategy for the stage N0 neck. Arch Otolaryngol Head Neck Surg. 1994;120:699-702.

Pitman

. Rationale for elective neck dissection. Am J Otolaryngol. 2000;21:31-37.

Iype

Sebastian

Mathew

. The role of selective neck dissection (I-III) in the treatment of node negative (N0) neck in oral cancer. Oral Oncol. 2008;44:1134-1138.

D’Cruz

Vaish

Kapre

. Elective versus therapeutic neck dissection in node-negative oral cancer. N Engl J Med. 2015;373:521-529.

Capote

Escorial

Muñoz-Guerra

. Elective neck dissection in early-stage oral squamous cell carcinoma: does it influence recurrence and survival? Head Neck. 2007;29:3-11.

Amit

Yen

Liao

. Clinical nodal stage is a significant predictor of outcome in patients with oral cavity squamous cell carcinoma and pathologically negative neck metastases: results of the international consortium for outcome research. Ann Surg Oncol. 2013;20:3575-3581.

Zhao

Guan

. Determination of lymph node micrometastases in patients with supraglottic carcinoma. Acta Otolaryngol. 2007;127:1188-1195.

10.

Woolgar

. The topography of cervical lymph node metastases revisited: the histological findings in 526 sides of neck dissection from 439 previously untreated patients. Int J Oral Maxillofac Surg. 2007;36:219-225.

11.

Ferlito

Rinaldo

Devaney

. Detection of lymph node micrometastases in patients with squamous carcinoma of the head and neck. Eur Arch Otorhinolaryngol. 2008;265:1147-1153.

12.

Woolgar

. Micrometastasis in oral/oropharyngeal squamous cell carcinoma: incidence, histopathological features and clinical implications. Br J Oral Maxillofac Surg. 1999;37:181-186.

13.

Yamazaki

Chiba

Hirai

. Clinical value of genetically diagnosed lymph node micrometastasis for patients with oral squamous cell carcinoma. Head Neck. 2005;27:676-681.

14.

Nieuwenhuis

EJC

Leemans

Kummer

. Assessment and clinical significance of micrometastases in lymph nodes of head and neck cancer patients detected by E48 (Ly-6D) quantitative reverse transcription-polymerase chain reaction. Lab Invest. 2003;83:1233-1240.

15.

Peyre

Hagen

DeMeester

. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg. 2008;248:549-556.

16.

Volpe

Driscoll

Douglass

. Outcome of patients with proximal gastric cancer depends on extent of resection and number of resected lymph nodes. Ann Surg Oncol. 2000;7:139-144.

17.

Herr

Bochner

Dalbagni

. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol. 2002;167:1295-1298.

18.

Johnson

T V

Hsiao

Delman

. Extensive inguinal lymphadenectomy improves overall 5-year survival in penile cancer patients: results from the Surveillance, Epidemiology, and End Results program. Cancer. 2010;116:2960-2966.

19.

Chen

Bilchik

. More extensive nodal dissection improves survival for stages I to III of colon cancer. Trans Meet Am Surg Assoc. 2006;124:267-275.

20.

Weir

Speers

D’yachkova

. Prognostic significance of the number of axillary lymph nodes removed in patients with node-negative breast cancer. J Clin Oncol. 2002;20:1793-1799.

21.

Shrime

Gullane

. Impact of nodal ratio on survival in squamous cell carcinoma of the oral cavity. Head Neck. 2009;31:1129-1136.

22.

Süslü

Hoşal

Sözeri

. Prognostic value of metastatic lymph node ratio in node-positive head and neck carcinomas. Am J Otolaryngol. 2010;31:315-319.

23.

Ebrahimi

Zhang

Gao

. Nodal yield and survival in oral squamous cancer: defining the standard of care. Cancer. 2011;117:2917-2925.

24.

Jaber

Zender

C a

Mehta

. Multi-institutional investigation of the prognostic value of lymph nodel yield in advanced-stage oral cavity squamous cell carcinoma. Head Neck. 2014;36:1446-1452.

25.

American Cancer Society. Cancer Facts & Figures 2015. Atlanta, GA: American Cancer Society; 2015.

26.

Gil

Carlson

Boyle

. Lymph node density is a significant predictor of outcome in patients with oral cancer. Cancer. 2009;115:5700-5710.

27.

Urban

Gluck

Pfeffer

. Lymph node ratio predicts the benefit of post-operative radiotherapy in oral cavity cancer. Radiother Oncol. 2013;106:74-79.

28.

Ebrahimi

Clark

Amit

. Minimum nodal yield in oral squamous cell carcinoma: defining the standard of care in a multicenter international pooled validation study. Ann Surg Oncol. 2014;21:3049-3055.

29.

Scully

Bagan

. Oral squamous cell carcinoma overview. Oral Oncol. 2009;45:301-308.

30.

Bello

Soini

Salo

. Prognostic evaluation of oral tongue cancer: means, markers and perspectives (II). Oral Oncol. 2010;46:636-643.

31.

Bagan

Sarrion

Jimenez

. Oral cancer: clinical features. Oral Oncol. 2010;46:414-417.

32.

Agrama

Reiter

Cunnane

. Nodal yield in neck dissection and the likelihood of metastases. Otolaryngol Head Neck Surg. 2003;128:185-190.

33.

Amit

Yen

Liao

. The origin of regional failure in oral cavity squamous cell carcinoma with pathologically negative neck metastases. JAMA Otolaryngol Head Neck Surg. 2014;140:1130-1137.

34.

Werning

Heard

Pagano

. Elective management of the clinically negative neck by otolaryngologists in patients with oral tongue cancer. Arch Otolaryngol Neck Surg. 2003;129:83.

35.

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers. Version 2.2013. Fort Washington, PA: National Comprehensive Cancer Network; 2013.